investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Skin ↓8.38   Biopharma ↓2.95   Disease: Oncology ↓2.34 «See more»   Equipment ↑2.88   Life Sciences ↑2.88   Food ↑2.88

Disease: Infectious stock segment: trending tickers

ASMB Assembly Biosciences, Inc. - Common Stock 3.73% 3.73% 0 + Disease: Infectious, Medicine, Biopharma

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1426800/000095017025001141/0000950170-25-001141-index.htm
8-K - ASSEMBLY BIOSCIENCES, INC. (0001426800) (Filer)
+ My List
CDTX Cidara Therapeutics, Inc. - Common Stock -2.12% down 0.00% -2.12 + Disease: Infectious, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1610618/000161061825000002/0001610618-25-000002-index.htm
8-K - Cidara Therapeutics, Inc. (0001610618) (Filer)
+ My List
EVFM Evofem Biosciences, Inc. - Common Stock 0.00% 0 + Women Health, Disease: Infectious, Reproductive health

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1618835/000149315224051174/0001493152-24-051174-index.htm
8-K - Evofem Biosciences, Inc. (0001618835) (Filer)
+ My List
FBRX Forte Biosciences, Inc. - Common Stock -8.38% -8.38% 0 + Skin, Medicine, Disease: Infectious, Biopharma

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1419041/000119312525012236/0001193125-25-012236-index.htm
8-K - Forte Biosciences, Inc. (0001419041) (Filer)
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock -6.32% -6.32% 0 + Disease: Infectious, Immunology, Cancer fight, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1760542/000110465925007015/0001104659-25-007015-index.htm
8-K - HOOKIPA Pharma Inc. (0001760542) (Filer)
+ My List
ITRM Iterum Therapeutics plc - Ordinary Share -6.71% up -13.42% 6.71 + Pharmaceutical , Medicine, Disease: Infectious

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1659323/000095017025015857/0000950170-25-015857-index.htm
10-K - Iterum Therapeutics plc (0001659323) (Filer)
+ My List
MBRX Moleculin Biotech, Inc. - Common Stock 2.38% 2.38% 0 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious

Last highlighted: S-1/A Sec report https://www.sec.gov/Archives/edgar/data/1659617/000143774925002083/0001437749-25-002083-index.htm
S-1/A - Moleculin Biotech, Inc. (0001659617) (Filer)
+ My List
NVAX Novavax, Inc. - Common Stock 0.60% down 1.33% -0.73 + Covid (fighting), Medicine, Disease: Infectious

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1000694/000110465925002863/0001104659-25-002863-index.htm
8-K - NOVAVAX INC (0001000694) (Filer)
+ My List
QDEL Quidel Corporation - Common Stock 1.83% 1.83% 0 + Medicine, Disease: Infectious, Immunology
+ My List
QTRX Quanterix Corporation - Common Stock -2.34% -2.34% 0 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1503274/000150327425000010/0001503274-25-000010-index.htm
8-K - Quanterix Corp (0001503274) (Filer)
+ My List
SPRO Spero Therapeutics, Inc. - Common Stock -4.65% -4.65% 0 + Disease: Infectious, Biopharma, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1701108/000119312525004063/0001193125-25-004063-index.htm
8-K - Spero Therapeutics, Inc. (0001701108) (Filer)
+ My List
TOMZ TOMI Environmental Solutions, Inc. - Common Stock 2.88% 2.88% 0 + Disease: Infectious, Medicine, Equipment, Life Sciences, Food, Covid (fighting)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/314227/000165495425000434/0001654954-25-000434-index.htm
8-K - TOMI Environmental Solutions, Inc. (0000314227) (Filer)
+ My List
ESLA Estrella Immunopharma, Inc. - Common Stock -2.5% -2.5% 0 + Biopharma, Cancer fight, Disease: Infectious
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.